In Brief: FTC prioritizes deceptive health claims; NAD rules on Farr, Migralex ads; Tainted weight-loss supplements; Atrium adds Russian distributor
This article was originally published in The Tan Sheet
Executive Summary
Deceptive health claims among FTC priorities; drugs in weight loss supplements; Farr modifies Prosta-Q claims; Migralex supports headache relief claims; Atrium acquires Russian distributor; GNC scores discount supplements; and J&J reopens baby powder plant in India
You may also be interested in...
POM Wonderful Asks Court To Vacate “Draconian” FTC Order
The nearly three-year battle between FTC and POM Wonderful moves to a federal appeals court, where the pomegranate juice and supplement firm asks the judges to nix the commission’s order that POM conduct two randomized controlled trials to support disease-related health claims.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.